Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders
- 12 June 2015
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Hypertension Reports
- Vol. 17 (7), 1-8
- https://doi.org/10.1007/s11906-015-0567-8
Abstract
Preclinical studies have convincingly demonstrated a role for the mineralocorticoid receptor (MR) in adipose tissue physiology. These studies show that increased MR activation causes adipocyte dysfunction leading to decreased production of insulin-sensitizing products and increased production of inflammatory factors, creating an environment conducive to metabolic and cardiovascular disease. Accumulating data also suggest that MR activation may be an important link between obesity and metabolic syndrome. Moreover, MR activation may mediate the pathogenic consequences of metabolic syndrome. Recent attempts at reversing cardiometabolic damage in patients with type 2 diabetes using MR antagonists have shown promising results. MR antagonists are already used to treat heart failure where their use decreases mortality and morbidity over and above the use of traditional therapies alone. However, more data are needed to establish the benefits of MR antagonists in diabetes, obesity, and metabolic syndrome.Keywords
This publication has 82 references indexed in Scilit:
- Role of mineralocorticoid receptor in insulin resistanceCurrent Opinion in Endocrinology, Diabetes and Obesity, 2012
- Role of mineralocorticoid receptor/Rho/Rho-kinase pathway in obesity-related renal injuryInternational Journal of Obesity, 2011
- Membrane Mineralocorticoid but not Glucocorticoid Receptors of the Dorsal Hippocampus Mediate the Rapid Effects of Corticosterone on Memory RetrievalNeuropsychopharmacology, 2011
- Association of plasma aldosterone with the metabolic syndrome in two German populationsActa Endocrinologica, 2011
- Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine isletsDiabetologia, 2011
- Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in miceJCI Insight, 2010
- Aldosterone Production and Insulin Resistance in Healthy AdultsJournal of Clinical Endocrinology & Metabolism, 2010
- Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic NephropathyJournal of the American Society of Nephrology, 2009
- Increased aldosterone among HIV-infected women with visceral fat accumulationAIDS, 2009
- Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-γ, and Proinflammatory AdipokinesCirculation, 2008